Plain-English translation of NCT06132685 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
After surgery to remove a brain tumor, patients typically receive a medication called to reduce swelling in the brain. This trial is testing whether patients can safely take this medication for just 4 days after surgery instead of the standard 15 days. Researchers want to know if the shorter course prevents side effects while still protecting patients from complications.
Steroids like can cause unwanted effects—such as high blood pressure, high blood sugar, infections, and mood changes—especially when used for longer periods. This trial aims to find out if using this medication for a shorter time after surgery could give patients the same protection with fewer risks.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the standard 15-day steroid course or the shorter 4-day course after your brain tumor surgery. You'll have blood drawn at surgery, at follow-up visits, and optionally at a wound check 10–14 days after surgery. You'll also have standard MRI and CT scans during your hospital stay, and your medical team will monitor you for any side effects or complications.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States